Medipharm Labs Corp LABS

TOR: LABS | ISIN: CA58504D1006   9/05/2024
0,080 CAD (-5,88%)
(-5,88%)   9/05/2024

8 mei 2024 · MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results · Persbericht

27 maart 2024 · MediPharm Labs Provides Conference Call Recording Details · Persbericht

27 maart 2024 · MediPharm Labs Reports Fourth Quarter and Full Year Results · Persbericht

25 maart 2024 · MediPharm Labs Provides Update on German Cannabis Legalization · Persbericht

22 maart 2024 · MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results · Persbericht

7 februari 2024 · MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority · Persbericht

22 december 2023 · MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program · Persbericht

8 november 2023 · MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results · Persbericht

25 oktober 2023 · MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash · Persbericht

2 oktober 2023 · MediPharm Labs Settles an Outstanding Claim for $9M · Persbericht

27 september 2023 · MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market · Persbericht

20 september 2023 · MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement · Persbericht

5 september 2023 · MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million · Persbericht

31 augustus 2023 · MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients · Persbericht

14 augustus 2023 · MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth · Persbericht

10 augustus 2023 · MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results · Persbericht

1 augustus 2023 · MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status · Persbericht

22 juni 2023 · MediPharm Labs Announces Change of Auditor · Persbericht

1 maart 2023 · MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study · Persbericht

8 december 2022 · MediPharm Labs Receives Award for CBD Brand of the Year · Persbericht

Mijn selecties